Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

The active ingredient reliably protects plants against the cucumber mosaic virus. Both plants were infected with the virus, but the specimen on the left in the picture was not protected.

See images of another tiny display with pixels the size of a human hair.

Survey data suggests that over a third of organizations that relied on US funding for HIV services had already closed by ...

Groundbreaking South African HIV cure trial shows 20% of participants maintaining viral suppression without medication for 18 months, marking a significant milestone in HIV research.

During medical school, I came across a professor who introduced me to research—up until that point, I was content with being ...

A combination of imaging techniques reveals how herpes simplex virus type 1 assembles within infected cells, highlighting the roles of essential viral proteins in viral assembly and exit.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

A clinical trial published in The Lancet suggests that a yearly injection of lenacapavir, developed by Gilead Sciences, is ...

The extracted information included the first author’s name and publication year, type of participants, age, country, sample size, study design ... to formulate simple cascade stage names, such as HIV ...

Determining whether HIV infection or antiretroviral therapy (ART) is responsible for increased CVD risk has been the focus of several studies. CVD risk is reduced in those with a higher CD4 + T ...